Heart patients face a higher risk of mortality when admitted during major cardiology conferences, according to a study from Australia. This finding raises concerns about the potential impact of conference-related staffing shortages on patient care and treatment delays. The study, published in Internal Medicine Journal, analyzed nearly two decades of data on 25,000 acute myocardial infarction (AMI) patients. Researchers compared patients admitted during the Cardiac Society of Australia and New Zealand (CSANZ) annual meeting to those admitted on similar days without a conference. The results showed a 30-day mortality rate of 11.3% for conference attendees, compared to 9.7% for non-conference patients. This suggests a statistically significant increase in mortality risk during these events. The study's authors, led by Dr. Timothy Nathan Kwan, caution against drawing causal conclusions, as the data only indicates an association. They propose several potential explanations, including delays in coronary angiogram procedures, reduced prescription of prognostic therapy, or misdiagnosis, but stress that these cannot be definitively proven with the available data. The findings have sparked debate, as similar studies from the United States have yielded conflicting results, with some suggesting mortality rates actually decrease during conferences. One theory posits that care is delayed during conferences, allowing patients to undergo treatment after the event. Another hypothesis is that less experienced cardiologists at teaching hospitals may have more responsibilities during conferences, potentially impacting patient care. The CSANZ authors emphasize the need for further research to understand the underlying mechanisms and to ensure high-quality patient care during these events, considering the potential benefits of scientific meetings in education and research.
